Biorestorative Therapies (BRTX) Projected to Post Earnings on Wednesday

Biorestorative Therapies (NASDAQ:BRTX – Get Free Report) is expected to be releasing its Q2 2026 resultson Wednesday, November 11th. Analysts expect the company to announce earnings of ($1.40) per share and revenue of $0.65 million for the quarter. Investors can check the company’s upcoming Q2 2026 earnings report page for the latest details on the call scheduled for Tuesday, November 17, 2026 at 3:30 PM ET.

Biorestorative Therapies Trading Up 5.3%

Shares of NASDAQ:BRTX opened at $1.60 on Tuesday. Biorestorative Therapies has a 12 month low of $1.28 and a 12 month high of $29.00. The company’s fifty day moving average price is $2.18 and its 200 day moving average price is $5.83.

Wall Street Analyst Weigh In

BRTX has been the topic of a number of recent research reports. Weiss Ratings restated a “sell (e+)” rating on shares of Biorestorative Therapies in a report on Monday, August 24th. Maxim Group cut shares of Biorestorative Therapies from a “buy” rating to a “hold” rating in a report on Tuesday, October 6th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Biorestorative Therapies presently has an average rating of “Reduce”.

Read Our Latest Report on BRTX

Biorestorative Therapies Company Profile

(Get Free Report)

BioRestorative Therapies, Inc is a biotechnology company focused on developing regenerative medicine products using cell and tissue-based technologies. The company’s programs are intended to address conditions for which existing treatment options may be limited, including musculoskeletal and metabolic disorders.

Its lead product candidate, BRTX-100, is an autologous cell therapy developed from a patient’s own bone marrow and designed to treat painful lumbar disc disease, including chronic lower-back pain associated with degenerated discs.

Featured Stories

Earnings History for Biorestorative Therapies (NASDAQ:BRTX)

Receive News & Ratings for Biorestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biorestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.